Anhui Huaheng Biotechnology Co Ltd
SSE:688639
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Anhui Huaheng Biotechnology Co Ltd
Revenue
Anhui Huaheng Biotechnology Co Ltd
Revenue Peer Comparison
600346
002648
000301
002493
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
A
|
Anhui Huaheng Biotechnology Co Ltd
SSE:688639
|
Revenue
¥1.9B
|
CAGR 3-Years
58%
|
CAGR 5-Years
36%
|
CAGR 10-Years
N/A
|
|
Z
|
Zhejiang Juhua Co Ltd
SSE:600160
|
Revenue
¥21.5B
|
CAGR 3-Years
10%
|
CAGR 5-Years
7%
|
CAGR 10-Years
8%
|
|
|
Hengli Petrochemical Co Ltd
SSE:600346
|
Revenue
¥237.1B
|
CAGR 3-Years
10%
|
CAGR 5-Years
30%
|
CAGR 10-Years
71%
|
|
|
Satellite Chemical Co Ltd
SZSE:002648
|
Revenue
¥40.9B
|
CAGR 3-Years
47%
|
CAGR 5-Years
32%
|
CAGR 10-Years
29%
|
|
|
Jiangsu Eastern Shenghong Co Ltd
SZSE:000301
|
Revenue
¥147.6B
|
CAGR 3-Years
81%
|
CAGR 5-Years
42%
|
CAGR 10-Years
67%
|
|
|
Rongsheng Petrochemical Co Ltd
SZSE:002493
|
Revenue
¥336.5B
|
CAGR 3-Years
41%
|
CAGR 5-Years
30%
|
CAGR 10-Years
27%
|
See Also
What is Anhui Huaheng Biotechnology Co Ltd's Revenue?
Revenue
1.9B
CNY
Based on the financial report for Dec 31, 2023, Anhui Huaheng Biotechnology Co Ltd's Revenue amounts to 1.9B CNY.
What is Anhui Huaheng Biotechnology Co Ltd's Revenue growth rate?
Revenue CAGR 5Y
36%
Over the last year, the Revenue growth was 37%. The average annual Revenue growth rates for Anhui Huaheng Biotechnology Co Ltd have been 58% over the past three years , 36% over the past five years .
You don't have any saved screeners yet
